Encompass Health Corp
24/7 Wall St. View
EHC at a Glance
- Market cap
- $12.2B
- P/E ratio
- 20.5
- Dividend yield
- 0.62%
- Revenue (TTM)
- $6.2B
- Profit margin
- 10.0%
- EPS (TTM)
- $6.02
- 52-week range
- $92 – $127
- 24/7 target
- $156.13
- Street target
- $148.17
- Next report
- Oct 28, 2026
Headquartered in Birmingham, AL Fiscal year ends December NYSE: EHC encompasshealth.com
About Encompass Health
Encompass Health Corporation (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. As of June 30, 2026, the company operates 176 rehabilitation hospitals across 39 states and Puerto Rico, with 67 of those being joint ventures. The company provides rehabilitative care for patients recovering from major injuries or illnesses such as stroke, traumatic brain injury, spinal cord injury, and hip fractures, using advanced technology and innovative treatments to maximize recovery. Encompass Health generates approximately 65.8% of its revenue from Medicare, 16.2% from Medicare Advantage, and 10.7% from managed care. The company employs approximately 43,300 people and discharged roughly 269,700 patients over the trailing four quarters, generating approximately $6.2 billion in trailing revenue. The company is actively expanding capacity through de novo hospital construction, bed additions to existing facilities, and a new small-format hospital strategy, with 18 inpatient rehabilitation facilities currently under development. Its growth targets for 2023-2027 include 6-10 de novo hospitals per year, 80-120 bed additions per year, and a 6%-8% discharge compound annual growth rate. Updated
Frequently Asked Questions
What does Encompass Health do?
Encompass Health Corporation (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. As of June 30, 2026, the company operates 176 rehabilitation hospitals across 39 states and Puerto Rico, with 67 of those being joint ventures.
What is the EHC stock price target?
24/7 Wall St.'s 12-month price target for EHC is $156.13, rated Buy. The Wall Street consensus target is $148.17. EHC price prediction →